series-b
Stage
2018
Founded
2
Investors
About
Boomerang Medical develops bioelectric neuromodulation technology for treating autoimmune diseases, specifically focusing on inflammatory bowel disease such as Crohn's disease and ulcerative colitis, and is conducting FDA-approved clinical trials.
Explore Boomerang Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.